Insider sales are immaterial relative to market cap and consistent with routine portfolio diversification. No bearish signal, monitor next quarterly earnings for any fundamental deterioration, but this cluster alone does not warrant action.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 30 $578.30entry
- T+1 · 4mo ago −0.21%α −0.93% · $577.11
- T+5 · 3mo ago +1.16%α −2.46% · $585.01
- T+20 · 3mo ago +5.75%α +1.79% · $611.57
- T+60 · 25d ago +15.72%α +13.25% · $669.20
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO and EVP of Operations at Medpace sold a combined $6.61M in open-market sales over two days at ~$600/share. The CEO sold 7,238 shares total ($4.35M) and the EVP sold 7,500 shares ($4.5M). At a $15.9B market cap, this represents ~0.04%, well below the 0.1% threshold for materiality, making this a routine, non-informative cluster of sales likely driven by diversification or tax planning rather than a bearish signal on the company's outlook. Per academic literature, cluster sales are weak predictors and should not be amplified beyond the proportionality band.
Key Financial Metrics
Key Facts
- CEO August J. Troendle sold 7,238 shares total (~$4.35M) on July 27-28, 2026 at ~$600/share
- EVP Susan E. Burwig sold 7,500 shares ($4.5M) on July 28, 2026 at $600/share
- Total cluster value of $6.61M represents ~0.04% of Medpace's $15.9B market cap
- Both sales were open-market (code S), no 10b5-1 plan designation in the filing
Financial Impact
$6.61M in insider sales, ~0.04% of market cap, trivial
Risk Factors
- Insider sales at $600 may indicate peak-price sentiment, though dollar amount is too small to be informative
- CEO selling alongside EVP could be coordinated tax planning, not a shared bearish view
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MEDP-1785382076210 |
Track record
24 reports on MEDP
5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +11.09% at T+20 after the Dec 4, 2025 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
- Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
- Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers